NUS Spinout Endofotonics Launches with New Cancer Diagnosis Technology


Using NGS as CDx Will Require Paradigm Shift, Regulatory Changes, According to Experts at AACR


Non-Profit Startup Paradigm Launches Cancer Panel Based on DNA, RNA Sequencing


Physicians' Plans to Implement NGS-based Tumor Tests Vary Widely, Study Finds


Last Week's Clinical Sequencing Papers of Note


People in the News: Jill Hagenkord, Robert Daber, Qingson Zhu


New Products: Genewiz's PGxOne


Qiagen Consolidates, Invests $10M in Maryland Facilities


Affymetrix, CollabRx Partner to Integrate Genomics Analysis Tools


Abbott's Q1 MDx Sales Rise 5 Percent